General
Major Phase III Alzheimer's drug trial fails after high expectations
 

Major Phase III Alzheimer's drug trial fails after high expectations

Shared by:

 
A major drug trial to treat mild dementia due to Alzheimer's disease that was much anticipated has failed after slightly promising data was released last year.
 
today.mims.com
 
27 Nov 2016 - General
 
In the recent months, I have read several news that were very optimistic about the results of this trial. However, as one of the key figures in the article mentioned, there is no clear causation between the deposition of amyloid plaques and the development of cognitive deficits. While it is very convenient to assume that cognitive deficits occur as a result of amyloid plaque deposition, this causation has not yet been proven. Treatment of Alzheimer's disease and other neurocognitive disorder...
 (Total 106 words)
It is very disappointed to know that the potential new treatment for to treat mild dementia, showed no significant in slowing the cognitive decline, comparing to placebo. It was an unsuccessful trial. It is a huge disappointment for the large population suffering from dementia. Alzheimer dementia remains a medical condition without an effective treatment or prevention. There are a few new treatment options that are still in the different phases of clinical trials, like the drug that target an e...
 (Total 110 words)